Taken together, these studies indicated that with upregulated NEIL3 expression, RCC and HCC may activate the tumor-suppressive function of the infiltrated immunocytes through cell interplay in TME, despite having substantial immune components. The gene discussed is NEIL3; the disease is renal cell carcinoma.